Pseudomonas aeruginosa alkaline protease blocks complement activation via the classical and lectin pathways

Journal of Immunology

Volumn 188, Issue 1, 2012, Pages 386-393

  Laarman, Alexander J ^a   Bardoel, Bart W ^a   Ruyken, Maartje ^a   Fernie, Job ^a   Milder, Fin J ^a   Van Strijp, Jos A G ^a   Rooijakkers, Suzan H M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PROTEINASE; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C5A;

ANIMAL CELL; ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT INHIBITION; COMPLEMENT LECTIN PATHWAY; CONTROLLED STUDY; ENZYME ACTIVITY; LEUKOCYTE FUNCTION; NEUTROPHIL; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PSEUDOMONAS AERUGINOSA;

BACTERIAL PROTEINS; COMPLEMENT C2; COMPLEMENT C3B; COMPLEMENT C5A; COMPLEMENT PATHWAY, MANNOSE-BINDING LECTIN; EXOPEPTIDASES; HUMANS; IMMUNE EVASION; NEUTROPHILS; PHAGOCYTOSIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; VIRULENCE FACTORS;

EID: 84855396914     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102162     Document Type: Article

References (44)

1. Kawai, T., and S. Akira. 2010. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11: 373-384.
2. Gros, P., F. J. Milder, and B. J. Janssen. 2008. Complement driven by conformational changes. Nat. Rev. Immunol. 8: 48-58.
3. Gasque, P. 2004. Complement: a unique innate immune sensor for danger signals. Mol. Immunol. 41: 1089-1098. (Pubitemid 39345390)
4. Endo, Y., M. Takahashi, and T. Fujita. 2006. Lectin complement system and pattern recognition. Immunobiology 211: 283-293.
5. Kemper, C., J. P. Atkinson, and D. E. Hourcade. 2010. Properdin: emerging roles of a pattern-recognition molecule. Annu. Rev. Immunol. 28: 131-155.
6. Klos, A., A. J. Tenner, K. O. Johswich, R. R. Ager, E. S. Reis, and J. Köhl. 2009. The role of the anaphylatoxins in health and disease. Mol. Immunol. 46: 2753-2766.
7. Hassett, D. J., M. D. Sutton, M. J. Schurr, A. B. Herr, C. C. Caldwell, and J. O. Matu. 2009. Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways. Trends Microbiol. 17: 130-138.
8. Kung, V. L., E. A. Ozer, and A. R. Hauser. 2010. The accessory genome of Pseudomonas aeruginosa. Microbiol. Mol. Biol. Rev. 74: 621-641.
9. Drenkard, E., and F. M. Ausubel. 2002. Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation. Nature 416: 740-743. (Pubitemid 34429150)
10. Schiller, N. L., R. A. Hatch, and K. A. Joiner. 1989. Complement activation and C3 binding by serum-sensitive and serum-resistant strains of Pseudomonas aeruginosa. Infect. Immun. 57: 1707-1713. (Pubitemid 19140132)
11. Matsumoto, K. 2004. Role of bacterial proteases in pseudomonal and serratial keratitis. Biol. Chem. 385: 1007-1016. (Pubitemid 39600308)
12. Hong, Y. Q., and B. Ghebrehiwet. 1992. Effect of Pseudomonas aeruginosa elastase and alkaline protease on serum complement and isolated components C1q and C3. Clin. Immunol. Immunopathol. 62: 133-138.
13. Parmely, M., A. Gale, M. Clabaugh, R. Horvat, and W. W. Zhou. 1990. Proteolytic inactivation of cytokines by Pseudomonas aeruginosa. Infect. Immun. 58: 3009-3014. (Pubitemid 20267696)
14. Bardoel, B. W., S. van der Ent, M. J. Pel, J. Tommassen, C. M. Pieterse, K. P. van Kessel, and J. A. van Strijp. 2011. Pseudomonas evades immune recognition of flagellin in both mammals and plants. PLoS Pathog. 7: e1002206.
15. Liehl, P., M. Blight, N. Vodovar, F. Boccard, and B. Lemaitre. 2006. Prevalence of local immune response against oral infection in a Drosophila/Pseudomonas infection model. PLoS Pathog. 2: e56.
16. Jaffar-Bandjee, M. C., A. Lazdunski, M. Bally, J. Carrère, J. P. Chazalette, and C. Galabert. 1995. Production of elastase, exotoxin A, and alkaline protease in sputa during pulmonary exacerbation of cystic fibrosis in patients chronically infected by Pseudomonas aeruginosa. J. Clin. Microbiol. 33: 924-929.
17. Döring, G., H. J. Obernesser, K. Botzenhart, B. Flehmig, N. Høiby, and A. Hofmann. 1983. Proteases of Pseudomonas aeruginosa in patients with cystic fibrosis. J. Infect. Dis. 147: 744-750.
18. Rooijakkers, S. H., J. Wu, M. Ruyken, R. van Domselaar, K. L. Planken, A. Tzekou, D. Ricklin, J. D. Lambris, B. J. Janssen, J. A. van Strijp, and P. Gros. 2009. Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor. Nat. Immunol. 10: 721-727.
19. Kuchma, S. L., J. P. Connolly, and G. A. O'Toole. 2005. A three-component regulatory system regulates biofilm maturation and type III secretion in Pseudomonas aeruginosa. J. Bacteriol. 187: 1441-1454. (Pubitemid 40305269)
20. Bestebroer, J., P. C. Aerts, S. H. Rooijakkers, M. K. Pandey, J. Köhl, J. A. van Strijp, and C. J. de Haas. 2010. Functional basis for complement evasion by staphylococcal superantigen-like 7. Cell. Microbiol. 12: 1506-1516.
21. Rooijakkers, S. H., M. Ruyken, A. Roos, M. R. Daha, J. S. Presanis, R. B. Sim, W. J. van Wamel, K. P. van Kessel, and J. A. van Strijp. 2005. Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nat. Immunol. 6: 920-927. (Pubitemid 43090447)
22. Roos, A., L. H. Bouwman, J. Munoz, T. Zuiverloon, M. C. Faber-Krol, F. C. Fallaux-van den Houten, N. Klar-Mohamad, C. E. Hack, M. G. Tilanus, and M. R. Daha. 2003. Functional characterization of the lectin pathway of complement in human serum. Mol. Immunol. 39: 655-668. (Pubitemid 35454078)
23. Feltzer, R. E., R. D. Gray, W. L. Dean, and W. M. Pierce, Jr. 2000. Alkaline proteinase inhibitor of Pseudomonas aeruginosa. Interaction of native and N-terminally truncated inhibitor proteins with Pseudomonas metalloproteinases. J. Biol. Chem. 275: 21002-21009. (Pubitemid 30481788)
24. Hancock, R. E., L. M. Mutharia, L. Chan, R. P. Darveau, D. P. Speert, and G. B. Pier. 1983. Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains. Infect. Immun. 42: 170-177. (Pubitemid 13012450)
25. Potempa, J., and R. N. Pike. 2009. Corruption of innate immunity by bacterial proteases. J. Innate Immun. 1: 70-87.
26. Laarman, A., F. Milder, J. van Strijp, and S. Rooijakkers. 2010. Complement inhibition by gram-positive pathogens: molecular mechanisms and therapeutic implications. J. Mol. Med. 88: 115-120.
27. Hadders, M. A., D. X. Beringer, and P. Gros. 2007. Structure of C8alpha-MACPF reveals mechanism of membrane attack in complement immune defense. Science 317: 1552-1554. (Pubitemid 47417434)
28. Nakamura, S., M. Shchepetov, A. B. Dalia, S. E. Clark, T. F. Murphy, S. Sethi, J. R. Gilsdorf, A. L. Smith, and J. N. Weiser. 2011. Molecular basis of increased serum resistance among pulmonary isolates of non-typeable Haemophilus influenzae. PLoS Pathog. 7: e1001247.
29. Gyetko, M. R., S. Sud, T. Kendall, J. A. Fuller, M. W. Newstead, and T. J. Standiford. 2000. Urokinase receptor-deficient mice have impaired neutrophil recruitment in response to pulmonary Pseudomonas aeruginosa infection. J. Immunol. 165: 1513-1519. (Pubitemid 30604586)
30. Qin, L., W. M. Quinlan, N. A. Doyle, L. Graham, J. E. Sligh, F. Takei, A. L. Beaudet, and C. M. Doerschuk. 1996. The roles of CD11/CD18 and ICAM-1 in acute Pseudomonas aeruginosa-induced pneumonia in mice. J. Immunol. 157: 5016-5021. (Pubitemid 126449581)
31. Cerquetti, M. C., D. O. Sordelli, J. A. Bellanti, and A. M. Hooke. 1986. Lung defenses against Pseudomonas aeruginosa in C5-deficient mice with different genetic backgrounds. Infect. Immun. 52: 853-857. (Pubitemid 16119854)
32. Höpken, U. E., B. Lu, N. P. Gerard, and C. Gerard. 1996. The C5a chemoattractant receptor mediates mucosal defence to infection. Nature 383: 86-89. (Pubitemid 26296466)
33. Larsen, G. L., B. C. Mitchell, T. B. Harper, and P. M. Henson. 1982. The pulmonary response of C5 sufficient and deficient mice to Pseudomonas aeruginosa. Am. Rev. Respir. Dis. 126: 306-311. (Pubitemid 12047094)
34. Laarman, A. J., M. Ruyken, C. L. Malone, J. A. van Strijp, A. R. Horswill, and S. H. Rooijakkers. 2011. Staphylococcus aureus metalloprotease aureolysin cleaves complement C3 to mediate immune evasion. J. Immunol. 186: 6445-6453.
35. Fujita, T. 2002. Evolution of the lectin-complement pathway and its role in innate immunity. Nat. Rev. Immunol. 2: 346-353. (Pubitemid 37328757)
36. Cryz, S. J., and B. H. Iglewski. 1980. Production of alkaline protease by Pseudomonas aeruginosa. J. Clin. Microbiol. 12: 131-133. (Pubitemid 10077062)
37. Duan, K., and M. G. Surette. 2007. Environmental regulation of Pseudomonas aeruginosa PAO1 Las and Rhl quorum-sensing systems. J. Bacteriol. 189: 4827-4836. (Pubitemid 47025595)
38. Kernacki, K. A., J. A. Hobden, L. D. Hazlett, R. Fridman, and R. S. Berk. 1995. In vivo bacterial protease production during Pseudomonas aeruginosa corneal infection. Invest. Ophthalmol. Vis. Sci. 36: 1371-1378.
39. Döring, G., A. Dalhoff, O. Vogel, H. Brunner, U. Dröge, and K. Botzenhart. 1984. In vivo activity of proteases of Pseudomonas aeruginosa in a rat model. J. Infect. Dis. 149: 532-537. (Pubitemid 14139036)
40. Kunert, A., J. Losse, C. Gruszin, M. Hühn, K. Kaendler, S. Mikkat, D. Volke, R. Hoffmann, T. S. Jokiranta, H. Seeberger, et al. 2007. Immune evasion of the human pathogen Pseudomonas aeruginosa: elongation factor Tuf is a factor H and plasminogen binding protein. J. Immunol. 179: 2979-2988.
41. Schmidtchen, A., E. Holst, H. Tapper, and L. Björck. 2003. Elastase-producing Pseudomonas aeruginosa degrade plasma proteins and extracellular products of human skin and fibroblasts, and inhibit fibroblast growth. Microb. Pathog. 34: 47-55. (Pubitemid 36287214)
42. Engel, L. S., J. M. Hill, A. R. Caballero, L. C. Green, and R. J. O'Callaghan. 1998. Protease IV, a unique extracellular protease and virulence factor from Pseudomonas aeruginosa. J. Biol. Chem. 273: 16792-16797. (Pubitemid 28311706)
43. Schiller, N. L., M. J. Alazard, and R. S. Borowski. 1984. Serum sensitivity of a Pseudomonas aeruginosa mucoid strain. Infect. Immun. 45: 748-755. (Pubitemid 14066196)
44. Speert, D. P., S. W. Farmer, M. E. Campbell, J. M. Musser, R. K. Selander, and S. Kuo. 1990. Conversion of Pseudomonas aeruginosa to the phenotype characteristic of strains from patients with cystic fibrosis. J. Clin. Microbiol. 28: 188-194. (Pubitemid 20050918)